RMD · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.15B | $4.69B | $4.22B | $3.58B | $3.20B | $2.96B | $2.61B | $2.34B |
| Cost of Revenue | $2.09B | $2.03B | $1.87B | $1.55B | $1.36B | $1.24B | $1.11B | $1.01B |
| Gross Profit | $3.05B | $2.66B | $2.36B | $2.02B | $1.84B | $1.72B | $1.49B | $1.33B |
| Research & Development | $331.28M | $307.52M | $287.64M | $253.57M | $225.28M | $201.95M | $180.65M | $155.15M |
| Selling, General & Administrative | $991.02M | $917.14M | $874.00M | $737.51M | $670.39M | $676.69M | $645.01M | $600.37M |
| Operating Expenses | $1.37B | $1.34B | $1.22B | $1.02B | $935.42M | $908.13M | $914.81M | $793.07M |
| Operating Income | $1.69B | $1.32B | $1.13B | $1.00B | $903.68M | $809.66M | $579.26M | $541.83M |
| Interest Expense | — | — | -$47.38M | -$22.31M | $23.99M | $40.38M | $36.16M | $28.36M |
| Other Income / (Expense) | -$7.80M | -$55.09M | -$30.21M | -$39.80M | -$20.02M | -$76.57M | -$60.42M | -$20.52M |
| Income Before Taxes | $1.68B | $1.26B | $1.10B | $960.48M | $883.66M | $733.09M | $518.85M | $521.31M |
| Provision for Income Taxes | $276.84M | $243.85M | $204.11M | $181.05M | $409.16M | $111.41M | $114.25M | $205.72M |
| Net Income | $1.40B | $1.02B | $897.56M | $779.44M | $474.50M | $621.67M | $404.59M | $315.59M |
| Basic EPS | $9.55 | $6.94 | $6.12 | $5.34 | $3.27 | $4.31 | $2.83 | $2.21 |
| Diluted EPS | $9.51 | $6.92 | $6.09 | $5.30 | $3.24 | $4.27 | $2.80 | $2.19 |
| Basic Shares Outstanding | 146.72M | 147.02M | 146.76M | 146.07M | 145.31M | 144.34M | 143.11M | 142.76M |
| Diluted Shares Outstanding | 147.34M | 147.55M | 147.46M | 147.04M | 146.45M | 145.65M | 144.48M | 143.99M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jun 2026 | $11.14 | $11.09 | $11.24 | 8 | ↑1 ↓2 |
| Jun 2027 | $12.05 | $11.74 | $12.24 | 8 | ↑1 ↓2 |
| Jun 2028 | $13.11 | $12.83 | $13.47 | 6 | ↑1 ↓0 |
| Jun 2029 | $14.22 | $14.22 | $14.22 | 1 | ↑0 ↓0 |